retatrutide ireland meets primary endpoints in two phase III obesity trials, reporting up to 22.6% weight loss – touchENDOCRINOLOGY Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13

























